AnaSpec will participate at the 13th International Peptide Symposium, which is held with the Australian Peptide Conference, from October 15th to 20...

Join us at the GLP-1 Based Therapeutics Summit from April 29 to May 1, 2025, to discover how our expertise supports R&D and early-phase development...

AnaSpec will participate at the TIDES USA 2024, from May 14th to 17th with Eurogentec in Boston, MA.

AnaSpec will be closed from Wednesday the 25th of December 2024 until Wednesday the 1st of January 2025.

[Insert Description]

[Article blog image should be : Minimum width: 800px and height: 600px]

PSC Biotech inspection results: AnaSpec meets the requirements to produce Active Pharmaceutical Ingredients (Drug Substance) according to current G...

Cyclic peptides are reshaping drug development and research, offering unique advantages over their linear counterparts. This article explores the d...

An EIND can be a patient’s lifeline. This article will examine the Emergency IND (EIND) process under the Expanded Access program and the pivotal r...

This article delves into the importance of selecting the right partner, focusing on the standards, expertise, and benefits they bring to the table.